Annual Report and Accounts and Notice of AGM
Appointment of joint broker
Board change
International Society for Cellular Therapy 2017 London Annual Meeting
5th Annual Cell & Gene Investor Day – Boston
7th Annual Advanced Therapies Summit
Proactive Investors: ReNeuron gears up for Phase III stroke disability study
Proactive Investors: ReNeuron ‘greatly encouraged’ by US regulator feedback on CTX cell therapy trial
Proactive Investors: CFO discusses very significant exosome therapy data
